We showed previously that statins induce anti-tumor effects on osteosarcoma cells [3–5], and lead to the down-regulation of cysteine rich protein 61 (CYR61/CCN1) expression level in these tumor cells [6]. This evidence concerns the gene CCN1 and osteosarcoma.